Does Insurance Cover Testosterone Treatments?

Disclosure: This page may contain affiliate or commercial relationships. | Last Updated: May 2026

MEDICAL DISCLAIMER This content is for informational purposes only and does not constitute medical advice. Consult a licensed physician before starting any hormone therapy or treatment.

Finding a treatment plan that finally addresses low testosterone feels like a massive relief—until you see the price tag. Whether you’re looking at gel, injections, or pellets, the long-term nature of Testosterone Replacement Therapy (TRT) makes insurance coverage a financial necessity rather than a luxury.

Navigating the “medical necessity” maze in 2026 isn’t just about having low numbers on a lab report; it’s about meeting specific, often rigid, criteria set by major carriers like Aetna, BCBS, and Cigna. A single missing lab value or a specific diagnosis code can be the difference between a standard $15 copay and a $400 monthly out-of-pocket expense.

This guide breaks down the current landscape of TRT coverage. 

The Short Answer: Is TRT Covered by Insurance?

Yes, most major health insurance plans can cover testosterone replacement therapy, but only when it is documented as medically necessary. That generally means two early-morning blood tests showing total testosterone below your insurer’s threshold (commonly 300 ng/dL, though some plans use 250 ng/dL), plus documented symptoms of hypogonadism such as low libido, fatigue, erectile dysfunction, or reduced muscle mass.

Coverage rules are similar across Aetna, Blue Cross Blue Shield, Cigna, and UnitedHealthcare, though each carrier has its own prior authorization process, formulary tiers, and preferred medications. Medicare can cover TRT under Part B (for clinician-administered injections) or Part D (for self-administered prescriptions), but it excludes coverage for age-related (late-onset) low testosterone unless there’s an identifiable underlying disorder. Medicaid coverage varies by state.

If insurance won’t cover your therapy, cash-pay testosterone is more affordable than many men assume. Generic injectable testosterone cypionate can run as low as $30 to $100 per month at retail pharmacies, while brand-name gels, patches, and pellets can cost several hundred dollars per month.

Prior Authorization and Step Therapy

Most insurers require prior authorization before they’ll cover testosterone. Your physician submits the request along with your labs, symptom documentation, and proposed treatment plan. Approval can take anywhere from a few days to several weeks, depending on the carrier and how complete the submission is.

Some plans also apply step therapy, which means you may need to try (and not respond to) a less expensive option such as a generic injection before the plan will cover a more expensive formulation such as a topical gel or long-acting injection. This is one of the most common reasons men shift to cash-pay clinics: the paperwork delays can stretch out treatment for weeks.

Carrier-by-Carrier Breakdown: Aetna, BCBS, Cigna, UnitedHealthcare

Each major carrier publishes its own clinical policy bulletin or formulary coverage guideline for testosterone. Here’s what to expect from the four largest commercial insurers in the United States.

Aetna

Aetna generally covers testosterone replacement therapy when medical necessity is established. According to Aetna’s clinical policy bulletins, that typically means two confirmed low morning testosterone readings, documented symptoms, and an evaluation of potential underlying causes. Aetna explicitly considers age-related (late-onset) hypogonadism an exclusion for certain long-acting formulations such as testosterone undecanoate.

Aetna also applies cost-effectiveness rules. For example, the plan may cover generic testosterone cypionate readily but require evidence of contraindication, intolerance, or treatment failure on cypionate before approving more expensive alternatives. Coverage of topical gels, patches, and pellets varies by plan tier.

Blue Cross Blue Shield (BCBS)

BCBS is a federation of independent plans, so coverage details can differ between states and product lines. That said, most BCBS plans follow the same general framework: documented hypogonadism with two low morning testosterone readings, clinical symptoms, and prior authorization. Many BCBS plans will preferentially cover generic injectable testosterone over brand-name gels, with brand formulations typically placed on higher cost-sharing tiers.

Because BCBS plans are state-specific, you’ll want to check your individual plan’s formulary and prior authorization requirements directly, either through your member portal or by calling the number on the back of your card.

Cigna

Cigna’s published coverage policies for injectable and topical testosterone require a confirmed diagnosis of hypogonadism, including at least two early-morning testosterone tests showing low levels, plus an evaluation of the cause of the deficiency. Cigna often requires prior authorization and ongoing monitoring to maintain coverage.

Cigna plans can vary widely. Some cover multiple delivery methods (injections, gels, patches), while others may limit coverage to the most cost-effective option. As with most insurers, your provider’s documentation is the deciding factor. Incomplete prior authorization submissions are a leading cause of denials.

UnitedHealthcare (UHC)

UnitedHealthcare generally covers TRT when its medical necessity criteria are met: documented hypogonadism confirmed by two separate early-morning testosterone tests, clinical symptoms, and evaluation of the cause. UHC may require that reversible causes (such as obesity, sleep apnea, or certain medications) be addressed before or alongside TRT.

Coverage through UHC can differ by plan type (HMO, PPO, EPO). Many UHC plans require prior authorization, and topical gels may sit on a higher cost-sharing tier than generic injectables. Repeat lab monitoring is also typically required to continue coverage.

Quick Reference: What Each Major Carrier Typically Requires

Carrier	Typical Coverage Requirements	Common Restrictions
Aetna	Two morning testosterone readings below threshold, documented symptoms, evaluation of underlying causes.	Excludes age-related (late-onset) hypogonadism for some long-acting injectables; prefers generic cypionate.
Blue Cross Blue Shield	Confirmed hypogonadism, prior authorization, ongoing monitoring; rules vary by state plan.	Brand-name gels and pellets often on higher tiers; state-by-state variation.
Cigna	Two early-morning low testosterone readings, symptom documentation, evaluation of cause, prior authorization.	Some plans limit coverage to the most cost-effective formulation; incomplete PAs lead to denials.
UnitedHealthcare	Confirmed hypogonadism, two morning tests, symptoms, evaluation of reversible causes.	May require addressing obesity, sleep apnea, or medication causes first; topical gels on higher tiers.

If you are interested in exploring specific providers after reviewing your coverage options, check out our best TRT clinics roundup.

Does Medicare Cover TRT?

Yes, Medicare can cover testosterone replacement therapy, but the rules are more layered than with commercial plans. Coverage flows through different parts of Medicare depending on how the medication is administered.

Medicare Part B vs. Part D

Part B generally covers testosterone that is administered by a clinician in an outpatient setting, such as an in-office injection. Under Part B, Medicare typically pays 80% of the approved cost after you meet your deductible, and you’re responsible for the remaining 20% coinsurance.

Part D covers self-administered prescription forms of testosterone, including injections you give yourself, topical gels, and patches, when the medication is on your specific plan’s formulary. 

Costs under Part D vary based on the plan’s tier system, deductible, and any prior authorization rules. Starting in 2025 and continuing into 2026, Part D plans include an annual out-of-pocket cap, which provides meaningful financial relief for people who use TRT long-term.

What Medicare Excludes

An important exception: Medicare generally does not cover TRT for late-onset (age-related) hypogonadism without a clearly documented underlying disorder of the testicles, pituitary gland, or brain. In practical terms, if your low testosterone is attributed primarily to normal aging rather than a specific medical condition, Medicare may decline coverage.

Medicare also excludes coverage for individuals with prostate or breast cancer, and may exclude coverage following certain recent medical events. Prior authorization and lab documentation of medical necessity are typically required for any Medicare-covered TRT prescription.

Medicare Advantage Plans

Medicare Advantage (Part C) plans must cover at least what original Medicare covers, but their out-of-pocket structures differ. In 2025, in-network out-of-pocket limits for Medicare Advantage are $9,350, with a combined in-network and out-of-network limit of $14,000. Many Medicare Advantage plans also use evidence-based criteria for reviewing TRT requests, which can either streamline approvals or add additional documentation steps.

ALSO READ: How to Get TRT Online

What About Medicaid?

Medicaid coverage for TRT is set by each state, so what’s covered in one state may be denied in another. In most states, medically necessary TRT is covered when there is documented hypogonadism (confirmed by lab results and symptoms), but prior authorization is almost always required, and state formularies often favor lower-cost formulations such as injectable testosterone over branded gels or pellets.

If you have Medicaid, your best move is to call your state’s Medicaid pharmacy program directly, or have your provider verify formulary status and prior authorization rules before submitting a prescription. Coverage for gender-affirming hormone therapy under Medicaid has also expanded in many states but remains state-specific.

Key Variables That Affect Whether Insurance Will Cover Testosterone

Even within the same insurance carrier, two people can end up with very different coverage outcomes. A handful of factors usually decide which way the decision goes.

1. Your Lab Values and How They Were Drawn

Insurers want morning testosterone draws, typically between 7 and 11 a.m., on two separate days. Levels naturally fluctuate throughout the day, peaking in the morning. An afternoon draw that shows low testosterone may not satisfy your insurer’s medical necessity criteria, even if you’re symptomatic.

2. The Documented Cause of Low Testosterone

Carriers generally cover TRT more readily when there’s a clear primary cause (testicular failure, Klinefelter’s syndrome) or secondary cause (pituitary or hypothalamic dysfunction). Coverage may be more difficult to secure when the diagnosis is age-related or idiopathic low testosterone, particularly under Medicare.

3. Your Plan Type and Formulary

HMO plans tend to require referrals and stricter prior authorization. PPO plans usually offer more flexibility but may still apply step therapy. Your formulary will dictate which formulations are covered and at what tier, which directly affects your copay.

4. Whether Reversible Causes Were Addressed

Some insurers require that reversible causes of low testosterone, such as obesity, untreated sleep apnea, opioid use, or certain prescription medications, be addressed before approving long-term testosterone therapy. If your provider hasn’t documented this evaluation, expect questions during prior authorization review.

What to Discuss With Your Healthcare Provider

Before you start TRT, a structured conversation with your provider can save you weeks of insurance back-and-forth. Bring a list of questions and be specific about your goals.

• Are my testosterone levels low enough to meet my insurer’s threshold for coverage?
• Were my morning testosterone draws done correctly, and on two separate days?
• Have we ruled out reversible causes like sleep apnea, certain medications, or weight-related factors?
• Which TRT formulation does my plan prefer, and is that the right fit clinically?
• What does the prior authorization process look like, and how long does it typically take?
• If I’m denied coverage, what is the appeals process and how often does it succeed?
• What ongoing labs and monitoring will I need, and how often?

Your provider’s office handles insurance questions regularly. Asking these questions early helps clarify whether you’re a good candidate, what your costs may look like, and whether your plan’s preferred formulation aligns with what’s clinically appropriate for you.

Frequently Asked Questions

Does insurance cover testosterone if my levels are borderline?

Often, no. Most insurers set hard thresholds (commonly 300 ng/dL) and require levels below that on two morning draws. If your levels are between 300 and 400 ng/dL but you have clear symptoms, you may be denied coverage, even though your symptoms warrant treatment. In that case, options include appealing the decision with detailed symptom documentation, requesting additional labs (such as free testosterone or SHBG), or considering cash-pay options.

Does Medicare cover TRT for men over 65 with low testosterone from aging?

Generally, no. Medicare typically excludes coverage for late-onset (age-related) hypogonadism unless an underlying disorder of the testicles, pituitary, or brain is documented. If your bloodwork identifies a specific medical cause, coverage becomes more likely. Otherwise, you may need to consider cash-pay options or Part D coverage with prior authorization.

Will my insurance cover testosterone gels and pellets, or just injections?

Most plans cover generic injectable testosterone with the fewest restrictions. Topical gels, patches, and pellets are often placed on higher cost-sharing tiers, and many plans require step therapy (trying a less expensive option first) before approving these. Brand-name gels like AndroGel are commonly tier 3 or higher with significant copays.

Can I appeal an insurance denial for TRT?

Yes, and appeals are frequently successful when supported by complete documentation. Your provider can submit an appeal letter with your full lab history, symptom checklist, and a clinical rationale tied to published guidelines. The appeals process can take several weeks but is worth pursuing if your symptoms are clearly documented.

How long does prior authorization take for TRT?

It varies by carrier and plan, but most prior authorizations are decided within several days to a few weeks. Incomplete submissions are the most common cause of delays. Making sure your provider includes both lab results and symptom documentation in the initial PA request can prevent unnecessary back-and-forth.

Does insurance cover the labs needed to qualify for TRT?

Usually yes, when your provider orders testosterone testing as part of evaluating documented symptoms. Some plans may require a specific diagnosis code or limit the frequency of testing. Confirm with your provider’s office and your plan’s formulary before scheduling repeat labs.

Is TRT covered by insurance if I’m using it for performance or anti-aging?

No. Insurance does not cover testosterone therapy for performance enhancement, bodybuilding, or general anti-aging purposes. Coverage is contingent on documented hypogonadism with confirmed lab values and clinical symptoms.

What’s the cheapest TRT option if my insurance won’t cover it?

Generic self-administered testosterone cypionate injections are typically the most affordable cash-pay option, often $30 to $100 per month before supplies and visits. Pharmacy discount programs, HSA/FSA funds, and bundled telehealth memberships can further reduce out-of-pocket costs.

Bottom Line: Is TRT Covered by Insurance for You?

For most men with clinically documented low testosterone and qualifying symptoms, the answer is yes, with the standard prior authorization process. Aetna, BCBS, Cigna, and UnitedHealthcare all generally cover TRT when medical necessity is established, though formulary tiers and preferred medications vary. Medicare can cover therapy through Part B or Part D, with the major caveat that age-related low testosterone often falls outside its coverage rules. Medicaid coverage is state-specific.

The practical takeaway: get your morning labs drawn on two separate days, work with a provider who knows how to document hypogonadism cleanly, and ask about prior authorization upfront. If your insurance won’t cover therapy, cash-pay generic injectables remain genuinely affordable for most budgets, and HSA or FSA funds can help.

If you’d rather skip the insurance paperwork entirely and start treatment quickly, PrescribedRX offers a streamlined telehealth path. Their licensed clinicians evaluate your labs and symptoms, then design a treatment plan with transparent monthly pricing and ongoing monitoring built in. It can be a sensible next step worth considering, especially if you’ve been stuck in prior authorization limbo or your levels fall just above your insurer’s threshold.

Ready to take the next step?

Book a TRT consultation with PrescribedRX to talk with a licensed clinician about your labs, symptoms, and the right treatment path for you.

This page may contain affiliate or commercial relationships. Content is informational and does not constitute medical advice. Always consult a licensed physician before starting, stopping, or changing any treatment plan.